| Title
of the article |
Treatment of microalbuminuria in hypertensive subjects with elevated cardiovascular risk: Results of the IMPROVE trial. |
| Authors |
Bakris GL, Ruilope L, Locatelli F, Ptaszynska A, Pieske B, de Champlain J, Weber MA, Raz I. |
| Journal
|
Kidney Int. 2007 Oct;72(7):879-85. Epub 2007 Aug 1. |
| Subject
Consultant |
F. Mallamaci |
| Score
(1 to 3 stars) |
** |
| Comments |
The results of this study suggest that patients with cardiovascular risk and relatively low albumin excretion rates in early-stage disease may only require monotherapy with renin–angiotensin–aldosterone blocking agents. |
